Hormonal therapy of renal cell carcinoma (RCC).
D000230:Adenocarcinoma / Q000032:analysis / Q000188:drug therapy* / Q000401:mortality; D000368:Aged; D005260:Female; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D007680:Kidney Neoplasms / Q000032:analysis / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D011987:Receptors, Steroid / Q000032:analysis; D013629:Tamoxifen / Q000627:therapeutic use
D006728:Hormones; D011987:Receptors, Steroid; D013629:Tamoxifen; D008525:Medroxyprogesterone